Joost de Bruijn
Founder bei KUROS BIOSCIENCES AG
Vermögen: 10 Mio $ am 31.03.2024
Profil
Joost D.
de Bruijn is the founder of Xpand Biotechnology BV (founded in 2005) and Progentix Orthobiology BV (founded in 2007).
He held the title of President & Chief Executive Officer at Xpand Biotechnology BV and Chief Executive Officer at Progentix Orthobiology BV.
Dr. de Bruijn is also the founder of Scinus Cell Expansion BV.
His current job is as a Professor at the University of London since 2014 and as a Professor at Queen Mary University of London since 2004.
His former jobs include being a Research Director at IsoTis SA and a Professor at the University of Twente from 2011 to 2019.
Dr. de Bruijn obtained his doctorate degree from the University of Leiden in 1993.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
KUROS BIOSCIENCES LTD.
3,97% | 31.12.2022 | 1 462 455 ( 3,97% ) | 10 Mio $ | 31.03.2024 |
Aktive Positionen von Joost de Bruijn
| Unternehmen | Position | Beginn |
|---|---|---|
| KUROS BIOSCIENCES AG | Founder | - |
| University of London | Corporate Officer/Principal | 18.03.2014 |
| Queen Mary University of London | Corporate Officer/Principal | 01.01.2004 |
Ehemalige bekannte Positionen von Joost de Bruijn
| Unternehmen | Position | Ende |
|---|---|---|
| University of Twente | Corporate Officer/Principal | 01.01.2019 |
| Scinus Cell Expansion BV | Founder | - |
IsoTis SA
 IsoTis SA BiotechnologyHealth Technology IsoTis SA develops biomedical products. Its product include proprietary natural and synthetic bone graft substitutes and other related medical devices. These devices are used to enhance the repair and regeneration of bone in spinal and trauma surgery, joint replacements and dental applications. IsoTis' products are primarily used spinal fusion, trauma, joint revision, bone void filling and iliac crest backfills procedures. The company is headquartered in Lausanne, Switzerland. | Chief Tech/Sci/R&D Officer | - |
Xpand Biotechnology BV
 Xpand Biotechnology BV BiotechnologyHealth Technology Xpand Biotechnology BV develops innovative technologies in the area of cell cultivation and regenerative medicine. Its bioreactor system enables clinical scale cell cultivation in a controlled environment and provides a cost effective alternative to 2 dimensional cell growth in tissue culture flasks or cell stacks. The company was founded by Joost D. de Bruijin and Frank-Jan van der Velden in 2004 and is headquartered in Bilthoven, the Netherlands. | Chief Executive Officer | - |
Progentix Orthobiology BV
 Progentix Orthobiology BV Medical SpecialtiesHealth Technology Progentix Orthobiology BV develops CuriOs (TM), a unique suite of osteoconductive material products for clinical application in bone regenerative surgery. The company was founded by Joost Dick de Bruijn and Clemens A. van Blitterswijk in 2007 and is headquartered in Bilthoven, the Netherlands. | Chief Executive Officer | - |
Ausbildung von Joost de Bruijn
| University of Leiden | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| KUROS BIOSCIENCES AG | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Progentix Orthobiology BV
Progentix Orthobiology BV Medical SpecialtiesHealth Technology Progentix Orthobiology BV develops CuriOs (TM), a unique suite of osteoconductive material products for clinical application in bone regenerative surgery. The company was founded by Joost Dick de Bruijn and Clemens A. van Blitterswijk in 2007 and is headquartered in Bilthoven, the Netherlands. | Health Technology |
IsoTis SA
IsoTis SA BiotechnologyHealth Technology IsoTis SA develops biomedical products. Its product include proprietary natural and synthetic bone graft substitutes and other related medical devices. These devices are used to enhance the repair and regeneration of bone in spinal and trauma surgery, joint replacements and dental applications. IsoTis' products are primarily used spinal fusion, trauma, joint revision, bone void filling and iliac crest backfills procedures. The company is headquartered in Lausanne, Switzerland. | Health Technology |
Xpand Biotechnology BV
Xpand Biotechnology BV BiotechnologyHealth Technology Xpand Biotechnology BV develops innovative technologies in the area of cell cultivation and regenerative medicine. Its bioreactor system enables clinical scale cell cultivation in a controlled environment and provides a cost effective alternative to 2 dimensional cell growth in tissue culture flasks or cell stacks. The company was founded by Joost D. de Bruijin and Frank-Jan van der Velden in 2004 and is headquartered in Bilthoven, the Netherlands. | Health Technology |
| Scinus Cell Expansion BV |
